glp 1 and gut microbiome A Specific Microbiota Dysbiosis of Type 2 Diabetic Mice Induces GLP-1 Resistance through an Enteric NO-Dependent Gut-Brain Axis Mechanism: Cell Metabolism Gut microbiota interactions with anti-diabetic
Description
The Aesthetic Opportunity in Weight Loss Treatments For med spa owners, the integration of weight loss medications creates a natural pathway to additional aesthetic services
A., Loizides-Mangold U., et al
Who Is Most at Risk: Clinical and Genetic Considerations Patients experiencing significant nausea or vomiting early in treatment show higher rates of temperature dysregulation
Staying on the drugs also did not appear to substantially increase the risks for low or high birth weight or major congenital malformations, although estimates for these outcomes were imprecise
& Bloomgren, G
Some patients need slower titration
